Skip to main content
Caplight Logo









Protean BioDiagnostics

Protean BioDiagnostics

Private
Orlando, FloridaHealthcare & Life Scienceshttps://www.proteanbiodx.com/

Last Round

Debt

Sep 16, 2025

Total Funding Raised

$300,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Protean BioDiagnostics is a biotechnology company that provides precision oncology diagnostic services, including digital pathology, molecular diagnostics, and AI-driven clinical trial matching for community cancer centers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Medical AI, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

precision oncologymolecular diagnosticsdigital pathologyliquid biopsyclinical decision supportcompanion diagnosticscancer screeningwhole exome sequencingclinical trial supportCLIA laboratoryCAP accreditationgenomic testingAI diagnosticsmedtechbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Protean BioDiagnostics Comparables

Compare Protean BioDiagnostics with similar companies based on industry and business-model similarity.

Protean BioDiagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OncoHost
79%
OncoDNA
77%
Roche Holding
75%

Protean BioDiagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtSep 16, 2025
AcceleratorMar 11, 2019

Key People

Founding team and executive leadership

Anthony Magliocco

President and CEO, Founder and President

Founding Team

Protean BioDiagnostics Investors

Notable investors and investment history

Protean BioDiagnostics investors
InvestorRounds
Tampa Bay Technology IncubatorAccelerator
Small Business AdministrationDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 16, 2025

    $300K round from Small Business Administration

  • May 8, 2024

    Grew 16% QoQ, from 19 to 22 employees.

Protean BioDiagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Protean BioDiagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Protean BioDiagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersOrlando, Florida
Employee Range11
Year Founded2017
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?